Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT07450859 is registered in ClinicalTrials.gov with BicycleTx Limited as lead sponsor.

NCT NCT07450859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07450859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Lead sponsor
BicycleTx Limited
Phase
Phase 2
Overall status
Recruiting
Start date
March 5, 2026
Completion date
May 31, 2029
Enrollment
39 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma (pdac)